Literature DB >> 16627046

From JNC I to JNC 7--what have we learned?

Marvin Moser1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16627046     DOI： 10.1016/j.pcad.2006.02.003

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  10 in total

Review 1.  Antihypertensive therapy and the J-curve: fact or fiction?

Authors:  Monique S Tanna; Sripal Bangalore
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

2.  Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence.

Authors:  Ann Marie Navar; Eric D Peterson; Daniel Wojdyla; Robert J Sanchez; Allan D Sniderman; Ralph B D'Agostino; Michael J Pencina
Journal:  JAMA       Date:  2016-11-15       Impact factor: 56.272

Review 3.  Treatment of hypertension in older persons: what is the evidence?

Authors:  John E Morley
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

4.  All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.

Authors:  Michael E Ernst; Barry L Carter; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

5.  Blood pressure goals for hypertension guidelines: what is wrong with "optimal"?

Authors:  Thomas D Giles
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 6.  Historical perspectives on the management of hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

7.  The treatment of hypertension: a remarkable success story.

Authors:  Marvin Moser; Edward J Roccella
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-11-26       Impact factor: 3.738

8.  Seven decades of progress.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-05       Impact factor: 3.738

9.  Optimizing hypertension control in patients with multiple cardiovascular risk factors.

Authors:  John Brian Copley
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

10.  Molecular mechanisms of experimental salt-sensitive hypertension.

Authors:  Bina Joe; Joseph I Shapiro
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.